Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians.

Autor: Sweet G; PGY-2 Psychiatric Pharmacy Resident, Veterans Affairs Health System of Western NY, Buffalo, New York. Previously: Department of Clinical Pharmacy Services, Saint John Medical Center, Tulsa, Oklahoma., Kim S; PGY-1 Pharmacy Resident, Oklahoma State University Medical Center, Tulsa, Oklahoma. Previously: University of Oklahoma College of Pharmacy, Tulsa, Oklahoma., Martin S; Assistant Professor of Psychiatry, Oklahoma State University Center for Health Sciences, Tulsa, Oklahoma. Previously: Department of Psychiatry, University of Oklahoma School of Community Medicine, Tulsa, Oklahoma., Washington NB; Medical Director, Crisis Care Center, Family and Children's Services, Tulsa, Oklahoma., Brahm N; Clinical Professor, University of Oklahoma College of Pharmacy, Tulsa, Oklahoma, Nancy-Brahm@ouhsc.edu.

Publikováno v: The mental health clinician [Ment Health Clin] 2018 Mar 26; Vol. 7 (4), pp. 156-159. Date of Electronic Publication: 2018 Mar 26 (Print Publication: 2017).

Use of visual cueing for blood glucose documentation in a person with schizophrenia and diabetes.

Autor: Watkins SC; W.W. Hastings Indian Hospital, Tahlequah, OK., Brahm NC; University of Oklahoma College of Pharmacy, Tulsa, OK., Washington NB; University of Oklahoma College of Medicine, School of Community Medicine, Tulsa, OK.

Publikováno v: Clinical schizophrenia & related psychoses [Clin Schizophr Relat Psychoses] 2014 Oct; Vol. 8 (3), pp. 152-6.

Probable quetiapine-mediated prolongation of the QT interval.

Autor: Aghaienia N; Department of Pharmacy Practice, Clinical and Administrative Sciences-Tulsa, University of Oklahoma College of Pharmacy, Tulsa, OK 74135, USA., Brahm NC, Lussier KM, Washington NB

Publikováno v: Journal of pharmacy practice [J Pharm Pract] 2011 Oct; Vol. 24 (5), pp. 506-12. Date of Electronic Publication: 2011 Aug 15.